Histopathology of Acetaminophen-Induced Liver Changes: RolE of Interleukin 1α and Tumor Necrosis Factor α

Toxicologic Pathology

Volumn 24, Issue 2, 1996, Pages 181-189

  Blazka, Mark E ^a   Elwell, Michael R ^a   Holladay, Steve D ^b   Wilson, Ralph E ^a   Luster, Michael I ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

Author keywords

antibody; centrilobular congestion; Female B6C3F1 mice; hepatotoxic; proinflammatory

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; IDITOL DEHYDROGENASE; INTERLEUKIN 1ALPHA; LACTATE DEHYDROGENASE; PARACETAMOL; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEGENERATION; CONTROLLED STUDY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER NECROSIS; LIVER PROTECTION; LIVER TOXICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANIMALS; ANTIBODIES; ENZYMES; FEMALE; HEPATITIS, TOXIC; INTERLEUKIN-1; LIVER; LIVER CIRCULATION; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; NECROSIS; RECEPTORS, INTERLEUKIN-1; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 0029871839     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262339602400206     Document Type: Article

References (36)

1. Arai K.-I., Lee F., Miyajima A., Miyatake S., Arai N., and Yokota T. (1990). Cytokines: Coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 59: 783-836.
2. Billiar TR, Curran RD, Williams DL, and Kispert PH (1992). Liver nonparenchymal cells are stimulated to provide interleukin 6 for induction of the hepatic acute-phase response in endotoxemia but not in remote localized inflammation. Arch. Surg. 127: 31-37.
3. Bird GLA, Sheron N., Goka J., Alexander G., and Williams RS (1990). Increased plasma tumor necrosis factors in severe alcoholic hepatitis. Ann. Intern. Med. 112: 917-920.
4. Blazka ME, Wilmer JL, Holladay SD, Wilson RE, and Luster MI (1995). Role of pro-inflammatory cytokines in acetaminophen hepatotoxicity. Toxicol. Appl. Pharmacol. 133: 43-52.
5. Brandes ME and Wahl SM (1994). Inflammatory cytokines: An overview. In: Xenobiotics and Inflammation, LB Schook and DL Laskin (eds). Academic Press, New York, pp. 33-70.
6. Decker K. (1990). Biologically active products of stimulated liver macrophages (Kupffer cells). Eur. J. Biochem. 192: 245-261.
7. Dejana E., Breviario F., Erroi A., Bussolino F., Mussoni L., Gramse M., Pintucci G., Casali B., Dinarello CA, Van Damme J., and Mantovani A. (1987). Modulation of endothelial cell functions by different molecular species of interleukin 1. Blood 69: 695-699.
8. Dinarello CA (1992). The role of interleukin-1 in host responses to infectious diseases. Infect. Agents Dis. 1: 227-236.
9. Dinarello CA and Thompson RC (1991). Blocking IL-1: Interleukin 1 receptor antagonist in vivo and in vitro. Immunol. Today 12: 404-410.
10. Farber JL, Leonard TB, Kyle ME, Nakae D., Serroni A., and Rogers SA (1988). Peroxidation-dependent and peroxidation-independent mechanisms by which acetaminophen kills cultured rat hepatocytes. Arch. Biochem. Biophys. 267: 640-650.
11. Ferrante A., Nandoskar M., Walz A., Goh DHB, and Kowanko IC (1988). Effects of tumor necrosis factor alpha and interleukin-1 alpha and beta on human neutrophil migration, respiratory burst and degranulation. Int. Arch. Allergy Appl. Immunol. 86: 82-91.
12. Fiers W. (1991). Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett. 285: 199-212.
13. Gerlach U. and Hiby W. (1974). Sorbitol dehydrogenase. In: Methods of Enzymatic Analysis, HU Bergmeyer (ed). Academic Press, New York, pp. 569-573.
14. Gerson RJ, Casini A., Gilfor D., Serroni A., and Farber JL (1985). Oxygen-mediated cell injury in the killing of cultured hepatocytes by acetaminophen. Biochem. Biophys. Res. Commun. 126: 1129-1137.
15. Henry RJ, Chiamori N., Golub OJ, and Berkman S. (1960). Revised spectrophotometric methods for the determination of glutamic-oxalacetic transaminase, glutamic-pyruvic transaminase and lactic acid dehydrogenase. Am. J. Clin. Pathol. 34: 381-398.
16. Jollow DJ, Mitchell JR, Potter WZ, Davis DC, Gillette JR, and Brodie BB (1973). Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J. Pharmacol. Exp. Therap. 187: 195-202.
17. Kayama F., Yoshida T., Elwell MR, and Luster MI (1995). Role of tumor necrosis factor-α in cadmium-induced hepatotoxicity. Toxicol. Appl. Pharmacol. 131: 224-234.
18. Laskin DL (1990). Parenchymal and nonparenchymal cell interactions in hepatotoxicity. Adv. Exp. Med. Biol. 283: 499-505.
19. Laskin DL (1992). Role of macrophages and endothelial cells in hepatotoxicity. In: Hepatocyte and Kupffer Cell Interactions, TR Billiar and RD Curran (eds). CRC Press, Boca Raton, Florida, pp. 147-168.
20. Laskin DL and Pilaro AM (1986). Potential role of activated macrophages in acetaminophen hepatotoxicity. I. Isolation and characterization of activated macrophages from rat liver. Toxicol. Appl. Pharmacol. 86: 204-215.
21. Laskin DL, Pilaro AM, and Ji S. (1986). Potential role of activated macrophages in acetaminophen hepatotoxicity. II. Mechanism of macrophage accumulation and activation. Toxicol. Appl. Pharmacol. 86: 216-226.
22. Le J. and Vilcek J. (1987). Tumor necrosis factor and interleukin 1: Cytokines with multiple overlapping biological activities. Lab. Invest. 56: 234-248.
23. McClain CJ and Cohen DA (1989). Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 9: 349-351.
24. McIntyre KW, Stepan GJ, Kolinsky KD, Benjamin WR, Plocinski JM, Kaffka KL, Campen CA, Chizzonite RA, and Kilian PL (1991). Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody. J. Exp. Med. 173: 931-939.
25. Mitchell JR, Jollow DJ, Potter WZ, Davis DC, Gillette JR, and Brodie BB (1973). Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J. Pharmacol. Exp. Ther. 187: 185-194.
26. Mitchell JR, Jollow DJ, Potter WZ, Gillette JR, and Brodie BB (1973). Acetaminophen-induced hepatic necrosis. IV. Role of glutathione. J. Pharmacol. Exp. Ther. 187: 211-217.
27. Mochida S., Ogata I., Ohta Y., Yamada S., and Fujiwara K. (1989). In situ evaluation of the stimulatory state of hepatic macrophages based on their ability to produce superoxide anions in rats. J. Pathol. 158: 67-71.
28. Muto Y., Nouri-Aria KT, Meager A., Alexander GJM, Eddleston Alwf, and Williams R. (1988). Enhanced tumor necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 2: 72-74.
29. Nathan CJ (1987). Secretory products of macrophages. J. Clin. Invest. 79: 319-326.
30. Potter WZ, Davis DC, Mitchell JR, Jollow DJ, Gillette JR, and Brodie BB (1973). Acetaminophen-induced hepatic necrosis. III. Cytochrome p-450-mediated covalent binding in vitro. J. Pharmacol. Exp. Ther. 187: 203-210.
31. Poulsen HE, Petersen P., and Vilstrup H. (1981). Quantitative liver function and morphology after paracetamol administration to rats. Eur. J. Clin. Invest. 11: 161-164.
32. Ramadori G., Van Damme J., Rieder H., and Meyer zum Buschenfelde K-H. (1988). Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1β and tumor necrosis factor-α. Eur. J. Immunol. 18: 1259-1264.
33. Sokol RR and Rohlf RJ (1969). Single classification analysis of variance. In: Biometry. Freeman, San Francisco, California, pp. 204-252.
34. Springer TA (1990). Adhesion receptors of the immune system. Nature (London) 346: 425-434.
35. Tracey KJ, Vlassara H., and Cerami A. (1989). Cachectin/tumour necrosis factor. Lancet 8647: 1122-1126.
36. Van der Poll T., Buller HR, Ten Cate H., Wortel CH, Bauer KA, Van Deventer SJH, Hack CE, Sauerwein HP, Rosenberg RD, and Ten Cate JW (1990). Activation of coagulation after administration of tumor necrosis factor to normal subjects. New Engl. J. Med. 322: 1622-1627.